You are here

  • Home
  • Archive
  • Volume 78, Issue 12
  • Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs

Article info

Article menu

Download PDFPDF

Systemic sclerosis
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
Free

Authors

  • Alexandru-Emil Matei Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Chih-Wei Chen Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Lisa Kiesewetter Translational Center Würzburg, Fraunhofer Translational Center Regenerative Therapies, Fraunhofer Institute for Silicate Research (ISC), Würzburg, Germany PubMed articlesGoogle scholar articles
  • Andrea-Hermina Györfi Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Yi-Nan Li Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Thuong Trinh-Minh Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Xiaohan Xu Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Cuong Tran Manh Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Toin van Kuppevelt Radboud Institute for Molecular Life Sciences, Department of Biochemistry, Radboud University Medical Center, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Jan Hansmann Translational Center Würzburg, Fraunhofer Translational Center Regenerative Therapies, Fraunhofer Institute for Silicate Research (ISC), Würzburg, Germany University for Applied Sciences Würzburg-Schweinfurt, Wurzburg, Germany PubMed articlesGoogle scholar articles
  • Astrid Jüngel Center of Experimental Rheumatology, University Hospital Zurich/Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Georg Schett Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Florian Groeber-Becker Translational Center Würzburg, Fraunhofer Translational Center Regenerative Therapies, Fraunhofer Institute for Silicate Research (ISC), Würzburg, Germany Department for Tissue Engineering and Regenerative Medicine, Würzburg University Medical Center, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Jörg H W Distler Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jörg H W Distler, Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen D-91054, Germany; joerg.distler{at}uk-erlangen.de
View Full Text

Citation

Matei A, Chen C, Kiesewetter L, et al
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
Annals of the Rheumatic Diseases 2019;78:1686-1692.

Publication history

  • Received July 30, 2019
  • Revised September 12, 2019
  • Accepted September 13, 2019
  • First published September 20, 2019.
Online issue publication 
May 23, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.